2
Clinical Trials associated with Enavogliflozin/METFORMIN HYDROCHLORIDEAn Anonymized, De-identified Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus
This observational study is designed to assess the effects of Envlo Tablet or Envlomet SR Tablet on weight loss and safety in patients with Type 2 diabetes, conducted in real primary care settings over a period of 24 weeks.
A Crossover, Randomized, Open-label, Comparison Study Between DWJ1525 and the Concomitant Use of DWP16001 and DWC202101 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
A Randomized, Open-label, Single Oral Dosing, Two-sequence, and Four-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of DWJ1525 and the Co-administration of DWP16001 and DWC202101 for Healthy Subjects in Fed and Fasted State
100 Clinical Results associated with Enavogliflozin/METFORMIN HYDROCHLORIDE
100 Translational Medicine associated with Enavogliflozin/METFORMIN HYDROCHLORIDE
100 Patents (Medical) associated with Enavogliflozin/METFORMIN HYDROCHLORIDE
100 Deals associated with Enavogliflozin/METFORMIN HYDROCHLORIDE